...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >2-(2-Substituted-3-(3,4-dichlorobenzylamino)propylamino)-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors.
【24h】

2-(2-Substituted-3-(3,4-dichlorobenzylamino)propylamino)-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors.

机译:2-(2-取代的-3-(3,4-二氯苄氨基)丙基氨基)-1H-喹啉-4-酮作为金黄色葡萄球菌甲硫氨酰-tRNA合成酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

New analogues of 2-[2-substituted-3-(3,4-dichlorobenzylamino)propylamino]quinolin-4-ones, 26a, 26b, 31a-e, 34, 35, 38 and 40, have been synthesized and evaluated against Staphylococcus aureus methionyl-tRNA synthetase. All of the synthesized compounds were less active than the reference compound 2. The compounds were also screened against various strains of S. aureus and Enterococci for their antibacterial activities. Among the compounds, 26b, 31c and 31e displayed significant inhibitory properties against various strains of Enterococci compared to compound 2.
机译:合成了2- [2-取代的-3-(3,4-二氯苄氨基)丙基氨基]喹啉-4-酮的新类似物26a,26b,31a-e,34、35、38和40,并针对葡萄球菌进行了评估金黄色的甲硫氨酰-tRNA合成酶。所有合成的化合物的活性均低于参考化合物2。还针对各种金黄色葡萄球菌和肠球菌菌株筛选了它们的抗菌活性。在化合物中,与化合物2相比,26b,31c和31e对各种肠球菌菌株表现出显着的抑制特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号